Well with minimal liquity on most OTC equities, the movement of the MM's is really just on a whim here and there and a few traders with small money interest can influence. So IMO, nothing real can be gleened from that with minimal volume.
I think the investment thesis here is rather simple. Either you are long and believe in the possibilities of their drug programs and current progress setting up for BP or similar deals, or you don't. If they cant create value with their programs then this flounders. If they do create valuae and strike a major deal, this will be a hard one to catch and will be one of those long rememebered story stocks of the OTC. IMO.
News 
Market Data 
Discover 
AI
